Terumo Cardiovascular announced it is discontinuing certification classes for the maintenance of its Advanced Perfusion System 1 Heart Lung Machine, a decision that adds to ongoing debates about right-to-repair in healthcare technology.
Abbott is recalling the HeartMate 3 LVAS due to issues with blood leakage and air entrapment during implantation.
The FDA cleared the CorVista System with CAD Add-On to evaluate the presence of significant coronary artery disease as an aid in diagnosis.
Terumo Cardiovascular announced it is discontinuing certification classes for the maintenance of its Advanced Perfusion System 1 Heart Lung Machine, a decision that adds to ongoing debates about right-to-repair in healthcare technology.
Getinge is recalling IABP devices due to a compromised intra-aortic balloon causing blood to enter the IABP during therapy.
Read More
The FDA granted Breakthrough Device Designation for CardioRenal Systems’ RenalGuard Therapy device for the prevention of acute kidney injury.
Read More
The FDA approved Abbott’s new transcatheter aortic valve implantation (TAVI) system, Navitor, to treat people with severe aortic stenosis.
Read More
Inspira Technologies, a respiratory support technology company, has signed an exclusive OEM agreement with Terumo Cardiovascular.
Read More
Researchers developed a prototype of a wearable device that continuously monitors all parameters associated with heart failure in real time.
Read More
Ultromics’ EchoGo Heart Failure, an AI solution for echocardiography to help diagnosis heart failure, received FDA clearance.
Read More
A study published in Nature Medicine reports the ability of a smartwatch ECG to accurately detect heart failure in nonclinical environments.
